Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Zanchin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos One|August 28, 2018
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiographyChristian Zanchin, Kyohei Yamaji, Carolin Rogge, et al.
European Heart Journal|September 1, 2016
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trialKyohei Yamaji, Lorenz Räber, Thomas Zanchin, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
International Journal of Cardiology|January 16, 2022
Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventionsChristian Zanchin, Stefan Ledwoch, Sarah Bär, et al.
European Heart Journal. Cardiovascular Imaging|September 15, 2020
Relationship between arterial remodelling and serial changes in coronary atherosclerosis by intravascular ultrasound: an analysis of the IBIS-4 studyKonstantinos C Koskinas, Rafaela Maldonado, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
JACC. Cardiooncology|August 16, 2021
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary InterventionYasushi Ueki, Benjamin Vögeli, Alexios Karagiannis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 18, 2020
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scoresYasushi Ueki, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|April 15, 2019
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesYasushi Ueki, Alexios Karagiannis, Christian Zanchin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos One|August 28, 2018
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiographyChristian Zanchin, Kyohei Yamaji, Carolin Rogge, et al.
European Heart Journal|September 1, 2016
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trialKyohei Yamaji, Lorenz Räber, Thomas Zanchin, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
International Journal of Cardiology|January 16, 2022
Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventionsChristian Zanchin, Stefan Ledwoch, Sarah Bär, et al.
European Heart Journal. Cardiovascular Imaging|September 15, 2020
Relationship between arterial remodelling and serial changes in coronary atherosclerosis by intravascular ultrasound: an analysis of the IBIS-4 studyKonstantinos C Koskinas, Rafaela Maldonado, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
JACC. Cardiooncology|August 16, 2021
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary InterventionYasushi Ueki, Benjamin Vögeli, Alexios Karagiannis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 18, 2020
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scoresYasushi Ueki, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|April 15, 2019
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesYasushi Ueki, Alexios Karagiannis, Christian Zanchin, et al.
Pageof 2